Palatin Technologies, Inc. (PTN)
Last updated: 2026-10-24 22:53:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Palatin Technologies, Inc. (PTN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $5.09, with a market capitalization of $9.81M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.92 to $31.00. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$9.81M | |
$5.44 | |
$1,472.50 | |
$0.09 | |
$5.51 | |
124.11K | |
68.71K | |
-- | |
$31.00 | |
$4.92 | |
-- | |
-- |
Palatin Technologies, Inc. (PTN) Latest Closing Stock Price
Palatin Technologies, Inc. (PTN) last closed at $5.51 as of 2026-10-23 23:31:00, unchanged from the previous close of $5.51.
During the latest regular trading session, PTN traded between $0.09 and $1,472.50, with a volume of 124.11K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Palatin Technologies, Inc. (PTN) 7-Day Stock Price Change
Over the past seven days, Palatin Technologies, Inc. (PTN) moved from $6.49 to $5.09, representing a decline of 21.54% ($1.40).
The stock traded between $4.92 and $8.00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 52.05 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
PTN 52-Week Price Position
Position in Range: 0.7%
PTN is currently trading at $5.09, placing it 0.7% of the way from its 52-week low of $4.92 to its 52-week high of $31.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Palatin Technologies, Inc. (PTN)?
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.
Palatin Technologies, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 25 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Palatin Technologies, Inc. (PTN) Stock on MEXC
Eligible investors can buy real shares of Palatin Technologies, Inc. (PTN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Palatin Technologies, Inc. (PTN) stock price today?
2.Is PTN stock going up or down today?
3.What is PTN pre-market price?
4.What is PTN after-hours price?
5.Is PTN stock trading now?
6.Where does PTN sit relative to its 52-week high and low?
7.What sector is Palatin Technologies, Inc. in?
8.What is Palatin Technologies, Inc.'s market capitalization and where is it listed?
9.How is PTN valued in terms of P/E ratio and EPS?
10.Does Palatin Technologies, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
PTN Stock Calculator
Estimate the value between PTN shares and USD.
PTN Shares to USD
1.00 PTN shares = 5.092 USD
Calculations are estimates based on the latest available price and are for reference only.


